Shares of Reckitt Benckiser Group plc (LON:RKT – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is GBX 6,109.17.
A number of brokerages recently weighed in on RKT. JPMorgan Chase & Co. raised their target price on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the stock a “neutral” rating in a report on Wednesday, November 26th. Deutsche Bank Aktiengesellschaft upped their target price on Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the company a “buy” rating in a report on Friday, October 24th. Royal Bank Of Canada increased their price objective on Reckitt Benckiser Group from GBX 6,000 to GBX 6,400 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Jefferies Financial Group reiterated a “hold” rating and issued a GBX 5,200 price objective on shares of Reckitt Benckiser Group in a report on Thursday, October 2nd. Finally, UBS Group reiterated a “buy” rating and issued a GBX 7,700 target price on shares of Reckitt Benckiser Group in a research note on Friday, October 17th.
View Our Latest Stock Analysis on Reckitt Benckiser Group
Insider Activity at Reckitt Benckiser Group
Reckitt Benckiser Group Trading Down 0.1%
Shares of LON:RKT opened at GBX 5,978 on Friday. The company has a quick ratio of 0.46, a current ratio of 0.69 and a debt-to-equity ratio of 110.26. The company’s 50-day moving average price is GBX 5,908.66 and its 200 day moving average price is GBX 5,598.29. The company has a market cap of £40.24 billion, a PE ratio of 32.85, a P/E/G ratio of 1.10 and a beta of 0.09. Reckitt Benckiser Group has a fifty-two week low of GBX 4,579 and a fifty-two week high of GBX 6,080.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Wall Street Stockpicker Names #1 Stock of 2026
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
- Nvidia x 1,000,000
- GOLD ALERT
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
